Log in

OTCMKTS:HLUYY - H. Lundbeck A/S- Stock Price, Forecast & News

0.00 (0.00 %)
(As of 02/16/2020 04:00 PM ET)
Today's Range
Now: $38.25
50-Day Range
MA: $40.39
52-Week Range
Now: $38.25
Volume263 shs
Average VolumeN/A
Market CapitalizationN/A
P/E Ratio16.21
Dividend YieldN/A
H. Lundbeck A/S engages in the research, development, production, and sale of pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, North America, and internationally. The company's principal products include Abilify Maintena for schizophrenia; Brintellix/Trintellix to treat depression; Northera for treating symptomatic neurogenic orthostatic hypotension; Onfi for Lennox-Gastaut syndrome; and Rexulti to treat depression/schizophrenia. Read More…

Industry, Sector and Symbol

Industry N/A



Sales & Book Value

Annual SalesN/A



Next Earnings Date2/18/2020 (Estimated)
OptionableNot Optionable

Receive HLUYY News and Ratings via Email

Sign-up to receive the latest news and ratings for HLUYY and its competitors with MarketBeat's FREE daily newsletter.

H. Lundbeck A/S- (OTCMKTS:HLUYY) Frequently Asked Questions

What is H. Lundbeck A/S-'s stock symbol?

H. Lundbeck A/S- trades on the OTCMKTS under the ticker symbol "HLUYY."

How were H. Lundbeck A/S-'s earnings last quarter?

H. Lundbeck A/S- (OTCMKTS:HLUYY) released its quarterly earnings results on Wednesday, November, 4th. The company reported $0.17 earnings per share for the quarter, beating analysts' consensus estimates of $0.01 by $0.16. The business had revenue of $547.05 million for the quarter, compared to the consensus estimate of $514.82 million. View H. Lundbeck A/S-'s Earnings History.

When is H. Lundbeck A/S-'s next earnings date?

H. Lundbeck A/S- is scheduled to release their next quarterly earnings announcement on Tuesday, February 18th 2020. View Earnings Estimates for H. Lundbeck A/S-.

Has H. Lundbeck A/S- been receiving favorable news coverage?

Media coverage about HLUYY stock has trended extremely negative recently, according to InfoTrie Sentiment Analysis. The research firm identifies positive and negative media coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. H. Lundbeck A/S- earned a coverage optimism score of -5.0 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the company's share price in the near future. View News Stories for H. Lundbeck A/S-.

What other stocks do shareholders of H. Lundbeck A/S- own?

Who are H. Lundbeck A/S-'s key executives?

H. Lundbeck A/S-'s management team includes the folowing people:
  • Dr. Deborah Dunsire, Pres & CEO (Age 57)
  • Mr. Anders Götzsche, Exec. VP & CFO (Age 52)
  • Mr. Lars Bang, Exec. VP of Product Devel. & Supply (Age 57)
  • Mr. Jacob Tolstrup, Exec. VP of Commercial Operations (Age 47)
  • Dr. Johan Luthman, Exec. VP and Head of R&D (Age 63)

How do I buy shares of H. Lundbeck A/S-?

Shares of HLUYY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is H. Lundbeck A/S-'s stock price today?

One share of HLUYY stock can currently be purchased for approximately $38.25.

MarketBeat Community Rating for H. Lundbeck A/S- (OTCMKTS HLUYY)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  176 (Vote Outperform)
Underperform Votes:  180 (Vote Underperform)
Total Votes:  356
MarketBeat's community ratings are surveys of what our community members think about H. Lundbeck A/S- and other stocks. Vote "Outperform" if you believe HLUYY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe HLUYY will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/16/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel